VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹716 Cr | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹716 Cr |
| Mar2024 | ₹627 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹579 Cr |
| Mar2021 | ₹556 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹716 Cr | 14.18 | |
| Mar2024 | ₹627 Cr | 4.28 | |
| Mar2023 | ₹601 Cr | 3.79 | |
| Mar2022 | ₹579 Cr | 4.19 | |
| Mar2021 | ₹556 Cr | - | |
Compare Total Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,307.5 Cr | 8.7% | 38.6% | 211.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 8.7% |
38.6% |
211.5% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses